Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Dementia

Clinical Trial Details

Overview

Research Study Summary

A clinical research study of Supressi. T-Diet plus Range and High Protein. T-Diet plus Range for the treatment of Alzheimer's Disease, Parkinson's Disease or Senile Dementia

Research Study Title

Clinical Evaluation of an Specific Diet for People With Dementia Disease

Purpose

The most common symptoms associated to senile dementia disease are confusion about schedules, hyperactivity... In this sense, these patients have frequently poor nutrition, resulting in malnutrition problems or malnutrition high risk.

To Learn more
Gender

Both Male and Female

Age

70 and up

Overall Status

Recruiting

Lead Sponsor

Vegenat, S.A.

Duration

23 Months

Facility Type

N/A

Eligibility

Both Male and Female ages 70 Years and up

Inclusion Criteria:

  • Patients over 70 years with neurologist or geriatrician dementia diagnosis (Alzheimer's disease, Parkinson's or mixed), with mild or moderate cognitive impairment degree (Between 24 and 14 MMSE).

  • Patients with or at malnutrition risk (Mini Nutritional Assessment screening positive)

Exclusion Criteria:

  • Patients with decompensated kidney failure, creatine and/or bilirubin greater than 2, uric acid higher than 8 mg/dl, and glomerular filtration under 60 ml/minute.

  • Patients with Diabetes mellitus poorly controlled (Glycemia > 200 mg/dl)

  • Patients with decompensated hypertension.

  • Patients with pharmacological treatment or consuming supplements containing specific supplementation of experimental product (omega 3 and/or vitamins supplements).

  • Post-stroke vascular dementias.

  • Do not achieve any inclusion criteria.

Site Locations (2)

Country State City Zip Facility and Contact
Spain Granada 18014 Clinical Nutrition and Dietetic Unit, University Hospital Virgen de las Nieves
Antonio J Pérez de la Cruz, MD, PhD
+ 34 639 236 825
antonioj.perez.sspa@juntadeandalulcia.es

Antonio J Pérez de la Cruz, MD, PhD
Principal Investigator
Spain Granada 18100 Department of Biochemistry and Molecular Biology II. University of Granada
Ángel Gil Hernández, PhD
+34 695 466 922
agil@ugr.es

Ángel Gil Hernández, PhD
Principal Investigator

Contact

Ángel Gil Hernández, PhD
+34 695 466 922

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

NCT ID: NCT01192529

Date Last Changed: June 21, 2012

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.